Jason S Debley
Overview
Explore the profile of Jason S Debley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
1012
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Hale M, Netland J, Chen Y, Thouvenel C, Nabel Smith K, Rich L, et al.
J Exp Med
. 2022 Aug;
219(9).
PMID: 35938988
Humoral immunity to SARS-CoV-2 can be supplemented with polyclonal sera from convalescent donors or an engineered monoclonal antibody (mAb) product. While pentameric IgM antibodies are responsible for much of convalescent...
12.
Vanderwall E, Barrow K, Rich L, Read D, Trapnell C, Okoloko O, et al.
Sci Rep
. 2022 Apr;
12(1):6972.
PMID: 35484173
Common alphacoronaviruses and human rhinoviruses (HRV) induce type I and III interferon (IFN) responses important to limiting viral replication in the airway epithelium. In contrast, highly pathogenic betacoronaviruses including SARS-CoV-2...
13.
14.
Chau A, Cole B, Debley J, Nanda K, Rosen A, Bamshad M, et al.
Pediatr Rheumatol Online J
. 2022 Mar;
20(1):19.
PMID: 35287710
No abstract available.
15.
Al-Shaikhly T, Murphy R, Parker A, Lai Y, Altman M, Larmore M, et al.
Eur Respir J
. 2022 Jan;
60(2).
PMID: 35027395
Background: Eosinophils are implicated as effector cells in asthma, but the functional implications of the precise location of eosinophils in the airway wall is poorly understood. We aimed to quantify...
16.
Mast F, Fridy P, Ketaren N, Wang J, Jacobs E, Olivier J, et al.
Elife
. 2021 Dec;
10.
PMID: 34874007
The emergence of SARS-CoV-2 variants threatens current vaccines and therapeutic antibodies and urgently demands powerful new therapeutics that can resist viral escape. We therefore generated a large nanobody repertoire to...
17.
Okoloko O, Vanderwall E, Rich L, White M, Reeves S, Harrington W, et al.
Front Pharmacol
. 2021 Dec;
12:765951.
PMID: 34867390
SARS-CoV-2 gains entrance to airway epithelial cells (AECs) through binding of the viral spike protein to the angiotensin-converting enzyme 2 (ACE2) on the cell surface. However, ACE2 also converts angiotensin...
18.
Vanderwall E, Barrow K, Rich L, Read D, Trapnell C, Okoloko O, et al.
bioRxiv
. 2021 Nov;
PMID: 34845445
Introduction: Common alphacoronaviruses and human rhinoviruses (HRV) induce type I and III interferon (IFN) responses important to limiting viral replication in the airway epithelium. In contrast, highly pathogenic betacoronaviruses including...
19.
Khatri S, Iaccarino J, Barochia A, Soghier I, Akuthota P, Brady A, et al.
Am J Respir Crit Care Med
. 2021 Nov;
204(10):e97-e109.
PMID: 34779751
The fractional exhaled nitric oxide (FE) test is a point-of-care test that is used in the assessment of asthma. To provide evidence-based clinical guidance on whether FE testing is indicated...
20.
Srivatsan S, Heidl S, Pfau B, Martin B, Han P, Zhong W, et al.
Clin Chem
. 2021 Jul;
68(1):143-152.
PMID: 34286830
Background: The urgent need for massively scaled clinical testing for SARS-CoV-2, along with global shortages of critical reagents and supplies, has necessitated development of streamlined laboratory testing protocols. Conventional nucleic...